Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agomelatine vs placebo plus sleep hygiene education in irritable bowel syndrome with insomnia
IRCT20260619069870N1Phase 3Recruiting
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in irritable bowel syndrome (IBS) and Insomnia comparing Agomelatine + sleep hygiene education with Placebo + sleep hygiene education (2 arms). Primary endpoint: Sleep quality. Started Jul 2026; status: recruiting.
02
Drugs
agomelatine
03
Conditions
irritable bowel syndrome (IBS)Insomnia
Beyond the preview
Go deeper on IRCT20260619069870N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260619069870N1.